Fergus Fleming

Fergus Fleming serves as Chief Technology Officer at RenalytixAI. RenalytixAI operates in the research sector with approximately 51.0 employees. RenalytixAI generates annual revenue of 2352000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • We have verified contacts for 2 executives at RenalytixAI.
• • Our database includes 201,469 c suite-level executives.

Salesforce Outlook Microsoft Office 365 Google Cloud Hosting WP Engine Google Tag Manager reCAPTCHA WordPress.org New Relic Google Font API Nginx Google Analytics Mobile Friendly Remote AI Android IoT

medical specialities health care biotechnology research kidney disease chronic kidney disease ckd kidney health diabetic kidney disease kidneyintelx risk assessment prognosis bioprognosis in vitro diagnostics artificial intelligence machine learning patient outcomes healthcare costs fda approval medicare coverage clinical management risk stratification biomarkers health systems electronic health records treatment plans patient engagement clinical workflows medication management healthcare innovations cost-effective healthcare personalized medicine patient risk clinical data integration healthcare transformation prognostic biomarkers clinical guidelines healthcare technology patient-centered care chronic illness management kidney function tests medical diagnostics healthcare providers care coordination early detection preventative care risk factors health disparities non-invasive testing patient education health outcomes monitoring treatment efficacy patient care optimization global health initiatives health wellness & fitness information technology & services health care information technology hospital & health care

CS

Christopher Scott COO at RenalytixAI

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

Outreach Guidance — research Sector

Executives like Fergus Fleming in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at RenalytixAI.

Fergus Fleming's Position in the MessageCEO Database

• •Fergus Fleming is 1 of 2 verified executive contacts we track at RenalytixAI.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •20 verified contacts work at research companies in the 51.0 employee range (same size as RenalytixAI).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Fergus Fleming directly?

Fergus Fleming's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Technology Officer at RenalytixAI. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Fergus Fleming work for?

Fergus Fleming is Chief Technology Officer at RenalytixAI, a company in the research sector with 51.0 employees.

Can I pitch or sell to Fergus Fleming?

As Chief Technology Officer at RenalytixAI, Fergus Fleming is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Fergus Fleming directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Fergus Fleming in?

Fergus Fleming works in the research industry as Chief Technology Officer at RenalytixAI. MessageCEO provides verified contact information for executives across all major industries.

Is Fergus Fleming's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Fergus Fleming's profile is kept up-to-date with the latest available information.

Last updated: July 24, 2026